Literature DB >> 25029250

[Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension].

Astrid Larisch1, Charlotte Neeb1, Martina de Zwaan2, Christian Pabst2, Henning Tiede3, Ardeschir Ghofrani3, Karen Olsson4, Marius Hoeper4, Johannes Kruse1.   

Abstract

BACKGROUND: The study investigated the level of mental distress in patients with pulmonary hypertension (PH) and assessed the use of and the wish for psychosomatic treatment.
METHODS: A total sample of n=187 outpatients participated in the cross-sectional survey. The short form of the Patient Health Questionnaire (PHQ-D), the EuroQol (EQ-5D) and a questionnaire assessing the wish for psychosomatic treatment were applied.
RESULTS: 50.6% of the patients exhibited depressive symptoms of varying degrees, 19.2% showed symptoms of major depression. 14.8% of the pa-tients reported panic attacks, and 7.1% demonstrated symptoms of a panic syndrome. Quality of life was low (EQ-5D VAS M=60). Experience with outpatient or inpatient psychotherapy was reported by 23.4% and 8.6% of the patients, respectively. 56.5% reported a wish for psychosomatic treatment.
CONCLUSIONS: PH-Patients are more likely to suffer from mild or subthreshold depressive syndromes, but are very interested in psychosomatic treatment. The implementation of psychosomatic interventions into clinical practice would be desirable. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25029250     DOI: 10.1055/s-0034-1377013

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  7 in total

1.  [Pulmonary hypertension: Possible genetic causes and therapeutic options].

Authors:  E Grünig; C A Eichstaedt; N Ehlken; E Mayer; H Klose
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 2.  Regulation and interactions in the activation of cell-associated plasminogen.

Authors:  H Myöhänen; A Vaheri
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

3.  Pathways to experiencing mental problems and need for mental support in patients with pulmonary arterial hypertension.

Authors:  Anna D T Muntingh; Sylvia Gerritsen; Neeltje M Batelaan; Harm Jan Bogaard
Journal:  Pulm Circ       Date:  2017-07-31       Impact factor: 3.017

4.  Anxiety and Depression in Patients With Pulmonary Arterial Hypertension in Northwest China: A Cross-Sectional Study.

Authors:  Juxia Zhang; Yuhuan Yin; Yujie Wen; Fugui Shi; Jiancheng Wang
Journal:  Front Psychiatry       Date:  2022-02-04       Impact factor: 4.157

5.  Childhood Trauma in Patients With PAH-Prevalence, Impact on QoL, and Mental Health-A Preliminary Report.

Authors:  Da-Hee Park; Tanja Meltendorf; Kai G Kahl; Jan C Kamp; Manuel J Richter; Henning Gall; Hossein A Ghofrani; Marius M Hoeper; Karen M Olsson; Jan Fuge
Journal:  Front Psychiatry       Date:  2022-02-10       Impact factor: 4.157

6.  Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial Hypertension.

Authors:  Da-Hee Park; Tanja Meltendorf; Kai G Kahl; Jan C Kamp; Manuel J Richter; Marius M Hoeper; Karen M Olsson; Jan Fuge
Journal:  Front Psychiatry       Date:  2022-02-22       Impact factor: 4.157

7.  Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.

Authors:  Da Hee Park; Jan Fuge; Tanja Meltendorf; Kai G Kahl; Manuel J Richter; Henning Gall; Hossein A Ghofrani; Jan C Kamp; Marius M Hoeper; Karen M Olsson
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.